amonafide has been researched along with caffeine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Liu, J; Qian, X; Shao, J; Shen, K; Xu, Y | 1 |
1 other study(ies) available for amonafide and caffeine
Article | Year |
---|---|
E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Caffeine; Cell Cycle Proteins; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; Dose-Response Relationship, Drug; E2F1 Transcription Factor; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gene Knockout Techniques; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; K562 Cells; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Naphthalimides; Organophosphonates; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Time Factors; Tumor Suppressor Protein p53 | 2012 |